Atopic dermatitis and the atopic march.

New insights into atopic dermatitis. J Clin Invest (2004) 5.09

The development of allergic inflammation. Nature (2008) 4.52

Epidermal barrier formation and recovery in skin disorders. J Clin Invest (2006) 4.14

A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet (2009) 2.96

Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol (2010) 2.72

Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci U S A (2005) 1.92

Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med (2009) 1.83

Animal models of atopic dermatitis. J Invest Dermatol (2009) 1.80

Diversity of the human skin microbiome early in life. J Invest Dermatol (2011) 1.77

Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol (2009) 1.76

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell (2013) 1.71

The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma Immunol Res (2011) 1.69

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both? Immunology (2004) 1.65

Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma. Proc Natl Acad Sci U S A (2009) 1.63

Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet (2012) 1.58

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol (2012) 1.56

The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol (2016) 1.47

Atopic dermatitis, atopic eczema, or eczema? A systematic review, meta-analysis, and recommendation for uniform use of 'atopic dermatitis'. Allergy (2016) 1.45

The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. Curr Opin Immunol (2010) 1.34

Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects. J Allergy Clin Immunol (2013) 1.30

Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J Clin Invest (2005) 1.30

Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis. Immunity (2015) 1.29

Anti-inflammatory and Anti-oxidative Effects of Korean Red Ginseng Extract in Human Keratinocytes. Immune Netw (2011) 1.28

The atopic march: what's the evidence? Ann Allergy Asthma Immunol (2009) 1.21

Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol (2007) 1.21

Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies. PLoS Med (2014) 1.13

Prevalence of atopic dermatitis in Korea: analysis by using national statistics. J Korean Med Sci (2012) 1.11

Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study. BMC Infect Dis (2011) 1.11

The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol (2014) 1.06

Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol (2012) 1.04

Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract (2010) 1.02

Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunol (2012) 1.02

Climate and prevalence of atopic eczema in 6- to 7-year-old school children in Spain. ISAAC phase III. Int J Biometeorol (2008) 0.98

Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol (2013) 0.98

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol (2014) 0.96

Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children. Pharmacotherapy (2008) 0.96

Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol (2013) 0.96

Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE. J Allergy Clin Immunol (2010) 0.96

A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet (2013) 0.95

Filaggrin gene mutation c.3321delA is associated with various clinical features of atopic dermatitis in the Chinese Han population. PLoS One (2014) 0.94

Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res (2014) 0.93

Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands. Eur J Health Econ (2010) 0.93

Innate immune responses in house dust mite allergy. ISRN Allergy (2013) 0.92

HTR7 Mediates Serotonergic Acute and Chronic Itch. Neuron (2015) 0.92

Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis. Clin Exp Allergy (2013) 0.92

Disorders of keratinisation: from rare to common genetic diseases of skin and other epithelial tissues. Ulster Med J (2007) 0.92

Genetic and environmental risk factors for childhood eczema development and allergic sensitization in the CCAAPS cohort. J Invest Dermatol (2009) 0.92

Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS One (2012) 0.91

Low-dose lipopolysaccharide affects lung allergic responses by regulating Jagged1 expression on antigen-pulsed dendritic cells. Int Arch Allergy Immunol (2011) 0.90

Effects of prenatal and perinatal exposure to fine air pollutants and maternal fish consumption on the occurrence of infantile eczema. Int Arch Allergy Immunol (2011) 0.90

Effectiveness of the Novel Herbal Medicine, KIOM-MA, and Its Bioconversion Product, KIOM-MA128, on the Treatment of Atopic Dermatitis. Evid Based Complement Alternat Med (2012) 0.90

Pathogenesis and disease mechanisms of occupational asthma. Immunol Allergy Clin North Am (2011) 0.90

Prevalence and comorbidity of allergic diseases in preschool children. Korean J Pediatr (2013) 0.90

Quality of life and disease severity are correlated in patients with atopic dermatitis. J Korean Med Sci (2012) 0.89

New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther (2013) 0.88

Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice. PLoS One (2012) 0.87

Does improvement management of atopic dermatitis influence the appearance of respiratory allergic diseases? A follow-up study. Clin Mol Allergy (2010) 0.87

Mutations in the Filaggrin are Predisposing Factor in Korean Children With Atopic Dermatitis. Allergy Asthma Immunol Res (2013) 0.87

The importance of TSLP in allergic disease and its role as a potential therapeutic target. Expert Rev Clin Immunol (2014) 0.86

Quality of life measures in Italian children with atopic dermatitis and their families. Ital J Pediatr (2011) 0.86

House dust mite-related allergic diseases: role of skin prick test, atopy patch test, and RAST in the diagnosis of different manifestations of allergy. Eur J Pediatr (2009) 0.86

Role of macrophage migration inhibitory factor in the Th2 immune response to epicutaneous sensitization. J Clin Immunol (2011) 0.85

Vitamin D and allergic disease: sunlight at the end of the tunnel? Nutrients (2011) 0.84

Intracellular production of IL-2, IL-4, IFN-gamma, and TNF-alpha by peripheral blood CD3+ and CD4+ T cells in children with atopic dermatitis. Eur J Pediatr (2006) 0.83

The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J Invest Dermatol (2013) 0.83

Different implications of paternal and maternal atopy for perinatal IgE production and asthma development. Clin Dev Immunol (2012) 0.83

Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy. J Immunol (2011) 0.83

Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol (2016) 0.83

Concurrent exposure to a dectin-1 agonist suppresses the Th2 response to epicutaneously introduced antigen in mice. J Biomed Sci (2013) 0.82

Occurrence of common allergic diseases in children with idiopathic nephrotic syndrome. J Epidemiol (2015) 0.82

Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants. Asia Pac Allergy (2015) 0.82

Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS One (2012) 0.81

High levels of both n-3 and n-6 long-chain polyunsaturated fatty acids in cord serum phospholipids predict allergy development. PLoS One (2013) 0.81

Severe eczema in infancy can predict asthma development. A prospective study to the age of 10 years. PLoS One (2014) 0.81

Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol (2015) 0.81

The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients. J Allergy Clin Immunol (2011) 0.81

Research statistics in atopic eczema: what disease is this? Ital J Pediatr (2012) 0.80

Association of prevalence of rhinitis, atopic eczema, rhinoconjunctivitis and wheezing with mortality from infectious diseases and with antibiotic susceptibility at a country level. Asia Pac Allergy (2015) 0.80

Skin barrier function and its importance at the start of the atopic march. J Allergy (Cairo) (2012) 0.80

Prevalence of allergic diseases and risk factors of wheezing in Korean military personnel. J Korean Med Sci (2011) 0.79

Obstructive sleep apnea and the risk of atopic dermatitis: a population-based case control study. PLoS One (2014) 0.79

Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood. Sci Total Environ (2011) 0.78

Effect on skin hydration of using baby wipes to clean the napkin area of newborn babies: assessor-blinded randomised controlled equivalence trial. BMC Pediatr (2012) 0.78

MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells. Clin Exp Immunol (2015) 0.78

Atopic March from Atopic Dermatitis to Asthma-Like Lesions in NC/Nga Mice Is Accelerated or Aggravated by Neutralization of Stratum Corneum but Partially Inhibited by Acidification. J Invest Dermatol (2015) 0.78

Eosinophilic oesophagitis: clinical presentation and pathogenesis. Postgrad Med J (2014) 0.77

Feeding bottles usage and the prevalence of childhood allergy and asthma. Clin Dev Immunol (2012) 0.77

ΔNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis. PLoS One (2014) 0.77

Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children: A nationwide population-based cohort study. Medicine (Baltimore) (2016) 0.77

Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen. J Biomed Sci (2009) 0.77

TSLP: A Key Regulator of Asthma Pathogenesis. Drug Discov Today Dis Mech (2012) 0.77

Age-Related Changes in Immunological Factors and Their Relevance in Allergic Disease Development During Childhood. Allergy Asthma Immunol Res (2016) 0.77

Characteristics and severity of asthma in children with and without atopic conditions: a cross-sectional study. BMC Pediatr (2015) 0.77

Trace metal exposure is associated with increased exhaled nitric oxide in asthmatic children. Environ Health (2016) 0.76

CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy Asthma Clin Immunol (2013) 0.76

The role of dendritic cells and monocytes in the maintenance and loss of respiratory tolerance. Curr Allergy Asthma Rep (2015) 0.76

Nonimmunoglobulin e-mediated immune reactions to foods. Allergy Asthma Clin Immunol (2006) 0.76

T-helper type-2 contact hypersensitivity of Balb/c mice aggravated by dibutyl phthalate via long-term dermal exposure. PLoS One (2014) 0.76

Particulate Oxidative Burden as a Predictor of Exhaled Nitric Oxide in Children with Asthma. Environ Health Perspect (2016) 0.76

A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates. BMC Dermatol (2012) 0.76

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics (2009) 3.29

Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol (2010) 2.87

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009) 2.00

Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A (2012) 1.90

Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum (2012) 1.87

Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet (2003) 1.86

Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol (2002) 1.83

Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J Invest Dermatol (2003) 1.67

Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol (2008) 1.64

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol (2003) 1.55

Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol (2006) 1.55

Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus. J Invest Dermatol (2012) 1.50

Impediments to research in pediatric dermatology: the results of a survey of the members of the society for pediatric dermatology. Pediatr Dermatol (2010) 1.39

Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet (2012) 1.38

Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum (2008) 1.36

Loss-of-function mutations of an inhibitory upstream ORF in the human hairless transcript cause Marie Unna hereditary hypotrichosis. Nat Genet (2009) 1.31

Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol (2010) 1.25

Venous malformations in blue rubber bleb nevus syndrome: variable onset of presentation. J Am Acad Dermatol (2004) 1.22

The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol (2005) 1.17

The acanthosis nigricans form of epidermal nevus. J Am Acad Dermatol (2006) 1.17

Pustular miliaria rubra: a specific cutaneous finding of type I pseudohypoaldosteronism. Pediatr Dermatol (2002) 1.13

Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc (2005) 1.13

The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol (2009) 1.10

Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res (2007) 1.06

Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis (2004) 1.02

Erythema dyschromicum perstans in prepubertal children. Pediatr Dermatol (2003) 1.02

Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing. Adv Healthc Mater (2014) 1.02

Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol (2002) 1.01

Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg (2012) 0.99

Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol (2013) 0.99

Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol (2004) 0.98

Incontinentia pigmenti in male patients. J Am Acad Dermatol (2006) 0.98

Ectodermal dysplasia-skin fragility syndrome resulting from a new homozygous mutation, 888delC, in the desmosomal protein plakophilin 1. J Am Acad Dermatol (2006) 0.96

Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem (2002) 0.95

Kawasaki disease: part II. Complications and treatment. J Am Acad Dermatol (2013) 0.94

Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol (2005) 0.94

Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions. J Invest Dermatol (2005) 0.93

Wnt signaling in focal dermal hypoplasia. Nat Genet (2007) 0.92

Commentary: "Leaning in" to support sex differences in basic science and clinical research. Endocrinology (2014) 0.91

Livedo reticularis in a child with moyamoya disease. Pediatr Dermatol (2003) 0.91

Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin. J Biol Chem (2003) 0.90

Pityriasis lichenoides in childhood: a retrospective review of 124 patients. J Am Acad Dermatol (2006) 0.90

Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem (2003) 0.90

LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr (2010) 0.88

Compound heterozygous mutations in the hairless gene in atrichia with papular lesions. J Invest Dermatol (2003) 0.88

Adhesion and migration, the diverse functions of the laminin alpha3 subunit. Dermatol Clin (2010) 0.88

Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics (2005) 0.88

Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg (2012) 0.87

The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol (2006) 0.87

Leukotriene receptor antagonists are ineffective for severe atopic dermatitis. J Am Acad Dermatol (2004) 0.87

Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol (2003) 0.86

AAD consensus statement on psoriasis therapies. J Am Acad Dermatol (2003) 0.84

Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr Dermatol (2014) 0.84

Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol (2013) 0.84

Ganglioside modulation regulates epithelial cell adhesion and spreading via ganglioside-specific effects on signaling. J Biol Chem (2002) 0.83

The yin and the yang of keratin amino acid substitutions and epidermolysis bullosa simplex. J Invest Dermatol (2011) 0.83

Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi. J Invest Dermatol (2013) 0.83

Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J Invest Dermatol (2002) 0.82

Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling. J Invest Dermatol (2002) 0.82

Prevalence and characterization of pruritus in epidermolysis bullosa. Pediatr Dermatol (2014) 0.82

Acute generalized exanthematous pustulosis in children. Arch Dermatol (2004) 0.82

De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation. Cancer Res (2009) 0.82

Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol (2007) 0.82

Lipid rafts: membrane triage centers. J Invest Dermatol (2006) 0.82

Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. J Am Acad Dermatol (2004) 0.81

Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis. Allergy Asthma Proc (2012) 0.81

Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole. J Am Acad Dermatol (2013) 0.81

Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma. Mol Cancer Res (2013) 0.81

Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. Clin Ther (2008) 0.80

Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew. Arch Dermatol (2009) 0.80

Pathogenesis-based therapies in ichthyoses. Dermatol Ther (2013) 0.80

New KIT mutations in patients with piebaldism. J Dermatol Sci (2004) 0.79

Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency. Am J Med Genet A (2013) 0.79

MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr (2008) 0.79

Intermittent etanercept therapy in pediatric patients with psoriasis. J Am Acad Dermatol (2010) 0.79

In this issue: The complexities of epidermolysis bullosa "simplex". J Invest Dermatol (2004) 0.78

GLI1 genotypes do not predict basal cell carcinoma risk: a case control study. Mol Cancer (2009) 0.78

Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling. J Invest Dermatol (2006) 0.78

Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti. J Clin Invest (2015) 0.78

"Free-floating" desmosomes in lipoid proteinosis: an inherent defect in keratinocyte adhesion? Pediatr Dermatol (2006) 0.77

Histologic and Immunohistochemical Features of the Skin Lesions in CANDLE Syndrome. Am J Dermatopathol (2015) 0.77

Improving the patient-clinician and parent-clinician partnership in atopic dermatitis management. Semin Cutan Med Surg (2012) 0.77

Dilute bleach baths for Staphylococcus aureus colonization in atopic dermatitis to decrease disease severity. Arch Dermatol (2011) 0.77

Current issues in atopic comorbidities and preventing the atopic march. Semin Cutan Med Surg (2012) 0.77

Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa. J Invest Dermatol (2010) 0.77

Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol (2010) 0.76

The relationship between obesity and psoriasis in the pediatric population: implications and future directions. Cutis (2013) 0.76

Practice gaps. Prescribing patterns by dermatologists and primary care providers for pediatric psoriasis: comment on "Trends in pediatric psoriasis outpatient health care delivery in the United States". Arch Dermatol (2012) 0.75

Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD. Prim Care Companion J Clin Psychiatry (2010) 0.75

In this issue: genotype-phenotype correlations: lessons learned from 'milder' genodermatoses. J Invest Dermatol (2003) 0.75

Infants with "hair today that's gone tomorrow": an inherited atrichia? Arch Dermatol (2003) 0.75

Eczema, Atopic Dermatitis, or Atopic Eczema: Analysis of Global Search Engine Trends. Dermatitis (2017) 0.75

Issues affecting specialty career paths in dermatology. J Drugs Dermatol (2007) 0.75

Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis. Eur J Dermatol (2010) 0.75

Molecular genetics of the inherited disorders of cornification: an update. Adv Dermatol (2002) 0.75

Intertriginous pustular psoriasis. J Am Acad Dermatol (2009) 0.75

Subgroup analyses of etanercept in pediatric patients with psoriasis. J Am Acad Dermatol (2010) 0.75

Congenital erosive and vesicular dermatosis with reticulated supple scarring: unifying clinical features. J Am Acad Dermatol (2013) 0.75

Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma. J Am Acad Dermatol (2010) 0.75

Acne and your pediatric patient: a roundtable discussion of treatment modalities and other factors. Cutis (2005) 0.75